Intellectual disability-spasticity-ectrodactyly syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Intellectual disability-spasticity-ectrodactyly syndrome | |
|---|---|
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Intellectual disability, spasticity, ectrodactyly |
| Complications | N/A |
| Onset | |
| Duration | |
| Types | |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | |
| Prevention | |
| Treatment | Supportive care, physical therapy |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Intellectual Disability-Spasticity-Ectrodactyly Syndrome (IDSES) is a rare genetic disorder characterized by a combination of intellectual disability, spasticity, and ectrodactyly. This syndrome represents a complex condition where affected individuals exhibit a range of physical and cognitive impairments. The syndrome is of genetic origin, though the specific genetic mutations and inheritance patterns may vary among individuals.
Symptoms and Characteristics[edit]
The primary features of Intellectual Disability-Spasticity-Ectrodactyly Syndrome include:
- Intellectual Disability: Individuals with IDSES typically present with varying degrees of cognitive impairment. This may range from mild learning disabilities to more severe intellectual challenges.
- Spasticity: This refers to a condition where certain muscles are continuously contracted. This contraction causes stiffness or tightness of the muscles and can interfere with movement, speech, and gait.
- Ectrodactyly: Ectrodactyly is a congenital malformation involving the absence of one or more central digits on the hands and/or feet. It is often referred to as "split hand/split foot malformation."
Additional symptoms may include other physical anomalies, such as craniofacial abnormalities, skeletal deformities, and issues with vision or hearing. The severity and combination of symptoms can vary significantly from one individual to another.
Causes and Genetics[edit]
The exact genetic cause of Intellectual Disability-Spasticity-Ectrodactyly Syndrome is not fully understood. It is believed to be a rare genetic disorder, possibly resulting from mutations in specific genes or a combination of genetic and environmental factors. The syndrome is likely inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Diagnosis[edit]
Diagnosis of IDSES involves a comprehensive evaluation, including a detailed medical history, physical examination, and genetic testing. Genetic testing can help identify mutations associated with the syndrome, although in many cases, the specific genetic cause may not be found. Diagnostic imaging, such as MRI or CT scans, may be used to assess physical anomalies and help in the diagnosis of spasticity.
Treatment and Management[edit]
There is no cure for Intellectual Disability-Spasticity-Ectrodactyly Syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Physical therapy and rehabilitation to manage spasticity and improve mobility
- Special education programs and cognitive therapy to support intellectual development
- Surgical interventions for ectrodactyly or other physical deformities, if necessary
- Regular follow-up with a multidisciplinary team of healthcare providers, including neurologists, orthopedic surgeons, and special education professionals
Prognosis[edit]
The prognosis for individuals with Intellectual Disability-Spasticity-Ectrodactyly Syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and supportive care can improve quality of life and help maximize an individual's potential.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
